Mouse CXCL13/BCA1 ELISA Kit KE10088 proteintech
$299.00
In stock
SKU
KE10088
| Product name | Mouse CXCL13/BCA1 ELISA Kit |
| Synonyms | Cxcl13,B lymphocyte chemoattractant,BCA1,Blc,CXC c |
| Reactivity | Mouse |
| Host / Isotype | United States |
| Tests | 1 X 96 well plate |
| Sample type | Serum, Plasma, Cell culture supernates |
| Assay type | Sandwich |
| Sensitivity | 2.3 pg/mL |
| Range | 15.6-1000 pg/mL |
| Tested applications | Sandwich ELISA |
| Gene ID (NCBI) | 55985 |
| Sample Type | Average Range |
| Mouse serum | 82% 69%-108% |
| Cell culture supernatants | 108% 99%-116% |
| Sample | n mean ( pg/mL ) SD CV% |
| 1 | 24 502.6 19.6 3.9 |
| 2 | 24 124.8 6.3 5.1 |
| 3 | 24 27.0 1.8 6.6 |
| Storage Instructions | All the reagents are stored at 2-8℃ for 6 months or -20℃ for 12 months. Refer to the protocol for further storage instructions. |
| mouse | Cerebrospinal fluid Exp Cell Res KPT-8602 combined with IFN-γ released ZBP1-PANoptosome to inhibit the progression of primary central nervous system lymphoma. Authors - Wei Jiang View Article |
Chemokine (C-X-C motif) ligand 13 (CXCL13), also known as B lymphocyte chemoattractant (BLC) or B cell-attracting chemokine 1 (BCA1), is a protein ligand. CXCL13 is chemotactic for B cells belonging to both the B-1 and B-2 subsets, and effects by interacting with chemokine receptor CXCR5. CCL19, CCL21 and CXCL13 expression are related to local immune responses to influenza virus infection in mice lung. CXCL13 also acts as inducers in early innate immunity and formation of protective lymphoid follicles within granulomas. CXCL13 expression has correlation with the pathogenesis of aberrant lymphoid structures, and acts as unfavorable prognosis in multiple sclerosis, Sjögren's, myasthenia gravis, and SLE. Properties Storage Instructions All the reagents are stored at 2-8℃ for 6 months or -20℃ for 12 months. Refer to the protocol for further storage instructions. Synonyms Cxcl13,B lymphocyte chemoattractant,BCA1,Blc,CXC c FAQ 1、I have limited sample diluent. How should I handle samples requiring high dilution factors? Answer: We recommend performing a serial dilution. For example, if human serum requires a 1,000,000-fold dilution, you can use a three-step 100× dilution method as follows: Step 1: Take 2 uL of human serum and add it to 198 uL of sample diluent, mix thoroughly to obtain a 100-fold diluted sample. Step 2: Take 2 uL of the 100-fold diluted sample and add it to 198 uL of sample diluent, mix thoroughly to obtain a 10,000-fold diluted sample. Step 3: Take 2 uL of the 10,000-fold diluted sample and add it to 198 uL of sample diluent, mix thoroughly to obtain a 1,000,000-fold diluted sample. If further dilution is required, additional serial steps can be used. We do not recommend using any other solutions or water for dilution, except for the sample diluent we suggest. If your sample diluent is still insufficient, please contact our customer service for more sample diluent.
Publications
- LILRB1 Is a Prognostic-Related Biomarker Correlated With Immune Infiltration in Head-Neck Squamous Cell Carcinoma.
Journal: Cancer Med | Authors: Shuai Chen | Species: mouse | Application: Cell culture supernates - KPT-8602 combined with IFN-γ released ZBP1-PANoptosome to inhibit the progression of primary central nervous system lymphoma.
Journal: Exp Cell Res | Authors: Wei Jiang | Species: mouse | Application: Cerebrospinal fluid - Identification and characterization of CXCL13 producers in bone tissue in response to fasting.
Journal: Int Immunol | Authors: Takuma Okawa
Reviews
Write Your Own Review